Skip to main content

Lilly Banks On Equity Investing To Grow Pipeline

By May 28, 2015News
MacroGenics-logo

MacroGenics-logo

Partnering with other pharma companies and academic institutions has been a cornerstone strategy for Eli Lilly and Company for close to a hundred years. One of the first major collaborations in the industry occurred in the 1920s when Lilly partnered with Frederick Banting and Charles Best from the University of Toronto. Banting and Best discovered insulin, and Lilly used its resources to develop and commercialize it. Today millions of people continue to benefit from the result of that successful collaboration.   

{iframe}http://www.clinicalleader.com/doc/lilly-banks-on-equity-investing-to-grow-pipeline-0001{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.